Prevalence of Functional defecatory disorder among patients with functional constipation and constipation predominant irritable bowel syndrome

被引：0
|
作者：
Goyal, Omesh [1 ]
Bansal, Monika [1 ]
Sood, Ajit [1 ]
机构：
[1] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP 0541
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [31] Tenapanor for constipation-predominant irritable bowel syndrome
    Siddiqui, S.
    Cash, B. D.
    [J]. DRUGS OF TODAY, 2020, 56 (03) : 203 - 210
  • [32] LubiprostoneIn Constipation-Predominant Irritable Bowel Syndrome
    Natalie J. Carter
    Lesley J. Scott
    [J]. Drugs, 2009, 69 : 1229 - 1237
  • [33] Lubiprostone In Constipation-Predominant Irritable Bowel Syndrome
    Carter, Natalie J.
    Scott, Lesley J.
    [J]. DRUGS, 2009, 69 (09) : 1229 - 1237
  • [34] Tegaserod for constipation-predominant irritable bowel syndrome
    Kale-Pradhan, Pramodini B.
    Wilhelm, Sheila M.
    [J]. PHARMACOTHERAPY, 2007, 27 (02): : 267 - 277
  • [35] Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)
    Mearin, F.
    Ciriza, C.
    Minguez, M.
    Rey, E.
    Mascort, J. J.
    Pena, E.
    Canones, P.
    Judez, J.
    [J]. ATENCION PRIMARIA, 2017, 49 (03): : 177 - 194
  • [36] Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome
    Serra, Jordi
    Caballero, Noemi
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (14) : 1969 - 1974
  • [37] Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study
    Koloski, N. A.
    Jones, M.
    Young, M.
    Talley, N. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (09) : 856 - 866
  • [38] Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)
    Zhao, Y. -F.
    Ma, X. -Q.
    Wang, R.
    Yan, X. -Y.
    Li, Z. -S.
    Zou, D. -W.
    He, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1020 - 1029
  • [39] Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China
    Lv, Chao-Lan
    Song, Geng-Qing
    Liu, Jie
    Wang, Wei
    Huang, Yi-Zhou
    Wang, Bo
    Tian, Jia-Shuang
    Yin, Meng-Qing
    Yu, Yue
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (41) : 5657 - 5667
  • [40] Prucalopride accelerates small bowel and colonic transit in patients with chronic functional constipation (FC) or constipation-predominant irritable bowel syndrome (C-IBS).
    Camilleri, M
    McKinzie, S
    Burton, D
    Thomforde, GM
    Zinsmeister, AR
    Bouras, EP
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A845 - A845
12345